Pharmafile Logo

Redefining digital ROI: Engagement, experience, and the new metrics of success

December 18, 2025 | Engagement, RoI, experience 

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and omnichannel initiatives.

- PMLiVE

As pressure grows on pharma teams to prove the value of their digital initiatives, traditional KPIs are falling short. Engagement rates and click-throughs only tell part of the story. What matters now is meaningful impact – for your audience, and your business.

In this webinar, we explored how pharma teams can evolve their digital measurement frameworks to capture what really counts. We discussed why traditional KPIs fall short in today’s pharma landscape, how to link engagement and experience to real-world outcomes, what ROI really means for digital and omnichannel investment and how to build actionable, insight-led measurement frameworks.

Latief Ziada, from Graphite, was joined by two expert panellists — Alyssa Fenoglio, Global Head of Digital Commercial, Teva Pharmaceuticals, and Florent Edouard, Global Head of the Digital Accelerator, Sanofi.

If you’re involved in digital decision-making within pharma, check it out.

Disclaimer: The opinions shared by our panellists are solely their own and should not be taken as representative of their organisations.

This content was provided by Graphite Digital

Company Details

 Latest Content from  Graphite Digital 

Demonstrating the value of UX research in pharma and healthcare

Demonstrating the value of UX research in pharma and healthcare can be difficult. Here, Graphite's Senior Clinical UX Researcher, Jack Burton, explains the importance of user research within the digital...

Overcoming challenges in digital pharma to get to launch quicker

We take a look at why it can take pharma businesses so long to get their digital products into the hands of patients or HCPs, and what can be done...

The Contradiction Conundrum: New digital pharma report

New research, based on the views of 450 pharma professionals, reveals contradictions in how pharma organisations are approaching their digital products and strategies.